Mr. Speaker, I would like to begin by thanking my hon. colleague for his question.
As I said earlier, we have made historic investments. Twelve days after the pandemic was declared, we were already making $192 million available to the biomanufacturing sector. On April 23, we announced an additional $600 million. In total, approximately one month after the pandemic began, we had invested close to $800 million.
I invite my colleague to tell the CEO with whom he spoke to contact me. I will gladly speak to him, just as I speak with anyone who wants to get in touch with us.
Of course we are prepared to support Canadian businesses. We have supported many and will continue to do so.